Safety and immune response of an experimental COVID-19 vaccine in healthy adults
Part of Infections, Lungs & breathing clinical trials.
This study tests an experimental COVID-19 vaccine to see if it is safe and how well it works against current variants. It is for healthy adults who have had a previous COVID-19 vaccine or infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 19 and 55 years old.
- Your body mass index (BMI) must be between 18 and 30.
- You must have had a COVID-19 vaccine or infection more than 3 months ago.
- You must be generally healthy, without serious medical conditions like heart, lung, or immune disorders.
- If you are female, you must not be pregnant or breastfeeding and must use effective birth control during the study.
- You must not have taken any investigational drugs or vaccines within the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new COVID-19 booster vaccine candidates in healthy adults who previously received mRNA COVID-19 vaccines. Researchers will monitor safety and how well your immune system responds to help develop better COVID-19 protection.
This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.
This study is a 'human challenge' trial where healthy volunteers who have been vaccinated and have low antibody levels are deliberately exposed to a newer Omicron variant of COVID-19. The goal is to learn how the virus spreads and how to test treatments or vaccines.
This trial tests a new COVID-19 vaccine called VYD2311, alone or with another COVID-19 vaccine, in healthy adults. The goal is to see if it is safe and helps your body fight the virus.
This study measures how strongly your immune system responds to COVID-19 vaccines. It includes people with newly diagnosed tuberculosis and a healthier comparison group, aiming to understand vaccine immune effects and safety.
This study tests a new injectable drug (VH4011499) for safety and how the body processes it. It's for healthy adults without HIV, and participants will get either the study drug or a placebo (an inactive shot).
Hear when a new Prevention of COVID-19 Variant (Omicron JN.1) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.